NXL insider filings

Nexalin Technology, Inc. — 46 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-17. Screen NXL transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 1 insider filing (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Greenlight Ventures, LLC — 10% owner1———

Recent insider filings — Nexalin Technology, Inc.

FiledFormInsiderReported transactionsSource
2026-11-173Greenlight Ventures, LLC — 10% ownerHoldings only — no transactions reportedEDGAR
2025-12-234White Mark — CEO, DirectorGrant/award (A): 1,000,000 (derivative) @ $0EDGAR
2025-12-234Van Fleet Justin — CFOGrant/award (A): 100,000 (derivative) @ $0EDGAR
2025-12-234Owens David — Chief Medical Officer, DirectorGrant/award (A): 1,000,000 (derivative) @ $0EDGAR
2025-12-234Shelton Carolyn Hamby — Sr. VP - Quality - RegulatoryGrant/award (A): 100,000 (derivative) @ $0EDGAR
2025-12-234Hu Ben — DirectorGrant/award (A): 100,000 (derivative) @ $0EDGAR
2025-12-234Kazden Alan — DirectorGrant/award (A): 100,000 (derivative) @ $0EDGAR
2025-09-304Owens David — Chief Medical Officer, DirectorGrant/award (A): 36,459 @ $0EDGAR
2025-09-304Hu Ben — DirectorGrant/award (A): 36,459 @ $0EDGAR
2025-09-304Kazden Alan — DirectorGrant/award (A): 36,459 @ $0EDGAR
2025-09-304OSSER LEONARD — 10% owner
Elson Marilyn
Grant/award (A): 83,333 @ $0EDGAR
2025-09-124Shelton Carolyn Hamby — Sr. VP - Quality - RegulatoryGrant/award (A): 20,000 (derivative) @ $0EDGAR
2025-09-124Owens David — Chief Medical Officer, DirectorGrant/award (A): 203,125 (derivative) @ $0 · Grant/award (A): 100,000 (derivative) @ $0EDGAR
2025-09-124Elson Marilyn — 10% owner
OSSER LEONARD — 10% owner
Sale (S): 23,150 (derivative) @ $0.02EDGAR
2025-07-214Elson Marilyn — 10% owner
OSSER LEONARD
Grant/award (A): 150,000 (derivative) @ $0 · Grant/award (A): 30,000 (derivative) @ $0 · Grant/award (A): 30,000 (derivative) @ $0 · Grant/award (A): 30,000 (derivative) @ $0 · Grant/award (A): 30,000 (derivative) @ $0 · Grant/award (A): 30,000 (derivative) @ $0EDGAR
2025-03-134Shelton Carolyn Hamby — Sr. VP - Quality, RegulatoryPurchase (P): 6,000 @ $2.20EDGAR
2025-02-274White Mark — President and CEO, DirectorGrant/award (A): 447,427 (derivative) @ $0 · Grant/award (A): 939,597 (derivative) @ $0EDGAR
2025-02-274Owens David — Chief Medical Officer, DirectorGrant/award (A): 139,821 (derivative) @ $0 · Grant/award (A): 654,363 (derivative) @ $0 · Grant/award (A): 125,000 (derivative) @ $0EDGAR
2025-02-054Owens David — Chief Medical Officer, DirectorPurchase (P): 1,000 @ $3.10EDGAR
2025-02-044Owens David — Chief Medical Officer, DirectorPurchase (P): 1,000 @ $2.98EDGAR
2025-01-294Owens David — Chief Medical Officer, DirectorPurchase (P): 1,500 @ $2.70EDGAR
2025-01-244Owens David — Chief Medical Officer, DirectorPurchase (P): 2,000 @ $2.50 · Purchase (P): 1,000 @ $2.70EDGAR
2024-10-304Owens David — Chief Medical Officer, DirectorPurchase (P): 500 @ $2.19EDGAR
2024-10-024Hu Ben — DirectorGrant/award (A): 175,000 @ $0EDGAR
2024-10-024Bernhard Leslie — DirectorGrant/award (A): 49,838 @ $0EDGAR
2024-10-024/AElson Marilyn — 10% owner
OSSER LEONARD
Grant/award (A): 700,000 @ $0EDGAR
2024-09-254Elson Marilyn — 10% owner
OSSER LEONARD
Grant/award (A): 700,000 @ $0EDGAR
2024-09-254/AElson Marilyn — 10% owner
OSSER LEONARD
Purchase (P): 36,000 (derivative) @ $0.40EDGAR
2024-08-154Owens David — Chief Medical Officer, DirectorPurchase (P): 1,000 @ $0.95EDGAR
2024-07-014Owens David — Chief Medical Officer, DirectorPurchase (P): 1,000 @ $1.75EDGAR
2024-06-214Owens David — Chief Medical Officer, DirectorPurchase (P): 1,619 @ $0.71EDGAR
2024-06-124Owens David — Chief Medical Officer, DirectorPurchase (P): 2,000 @ $0.65 · Purchase (P): 1,000 @ $0.62EDGAR
2023-10-054White Mark — President/CEO, DirectorPurchase (P): 25,000 (derivative) @ $0.40EDGAR
2023-10-054Owens David — Chief Medical Officer, DirectorPurchase (P): 2,500 (derivative) @ $0.40EDGAR
2023-10-054Kazden Alan — DirectorPurchase (P): 2,500 (derivative) @ $0.40EDGAR
2023-10-054Elson Marilyn — Ms. Elson serves as CFO, 10% owner
OSSER LEONARD
Purchase (P): 9,500 (derivative) @ $0.40EDGAR
2023-06-304/AMorad Rick — DirectorPurchase (P): 2,500 @ $4.15EDGAR
2023-06-304/AWhite Mark — President/CEO, DirectorPurchase (P): 25,000 @ $4.15EDGAR
2023-06-304/AKazden Alan — DirectorPurchase (P): 2,500 @ $4.15EDGAR
2022-09-294Elson Marilyn — Ms. Elson serves as CFO, 10% owner
OSSER LEONARD
Purchase (P): 9,500 @ $1.12EDGAR
2022-09-224/AWhite Mark — President/CEO, DirectorPurchase (P): 25,000 @ $4.15EDGAR
2022-09-204Morad Rick — DirectorPurchase (P): 2,500 @ $4.15EDGAR
2022-09-204Kazden Alan — DirectorPurchase (P): 2,500 @ $4.15EDGAR
2022-09-204Owens David — Chief Medical Officer, DirectorPurchase (P): 2,500 @ $4.15EDGAR
2022-09-204White Mark — President/CEO, DirectorPurchase (P): 2,500 @ $4.15EDGAR
2022-09-204Elson Marilyn — Ms. Elson serves as CFO, 10% owner
OSSER LEONARD
Purchase (P): 36,000 @ $4.15 · Purchase (P): 100,000 (derivative) @ $0.40EDGAR

Recent 8-K events — Nexalin Technology, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-10-018-K8.01 — Other EventsEDGAR
2026-10-018-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-288-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2026-09-028-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-08-278-K3.03 — Material Modification to Rights of Security Holders
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-218-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-208-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-178-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2026-08-118-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-07-298-K1.01 — Entry into a Material Definitive AgreementEDGAR

Registration filings — Nexalin Technology, Inc.

Securities Act registration lifecycles tracked for this issuer (live-forward since 2026-08-01), threaded by SEC file number.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=NXL returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs